Cumberland Pharmaceuticals Inc. CPIX · SEC Filings

88

Cumberland Pharmaceuticals Inc. functions as a specialized pharmaceutical enterprise, primarily invo...

Price5.37

Market Cap81.5 M

Float8.91 M

CountryUS

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 7, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 8, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Mar 6, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 7, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 8, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 9, 2025

News

TYPE

HEADLINE

FILED AT

Prospectus

TYPE

HEADLINE

FILED AT

424B5

ATM | Offering amount: $10,000,000 | Amount sold to date: $5,468,800 | Float: 8,730,126

Feb 14, 2025

424B5

ATM | Offering amount: $5,800,000 | Amount sold to date: $0 | Float: 7,913,120

Mar 20, 2024

424B5

ATM | Offering amount: $19,000,000 | Amount sold to date: $200,909 | Float: 8,616,340

Dec 27, 2021

424B4

Form 424B4 - Prospectus [Rule 424(b)(4)]

Aug 11, 2009

Registrations

TYPE

HEADLINE

FILED AT

S-3

SHELF | Offering amount: $100,000,000.00 EFFECTIVE

Dec 14, 2023

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

May 16, 2023

S-3

Common Stock- EFFECTIVE

Dec 11, 2020

S-3/A

Form S-3/A - Registration statement under Securities Act of 1933: [Amend]

Jan 8, 2018

S-3/A

Form S-3/A - Registration statement under Securities Act of 1933: [Amend]

Dec 18, 2017

S-3

Form S-3 - Registration statement under Securities Act of 1933

Nov 7, 2017

Proxies

TYPE

HEADLINE

FILED AT

Ownerships

TYPE

HEADLINE

FILED AT

4

Brown Martin S JR (Reporting)

Mar 20, 2026

4

Galante Joseph C (Reporting)

Mar 20, 2026

4

Jones James (Reporting)

Mar 20, 2026

4

Krogulski Kenneth (Reporting)

Mar 20, 2026

4

Young Caroline (Reporting)

Mar 20, 2026

4

Anthony Todd M. (Reporting)

Mar 20, 2026

Other

TYPE

HEADLINE

FILED AT

LETTER

Form UPLOAD - SEC-generated letter

Aug 25, 2025

CORRESP

Form CORRESP - Correspondence

Aug 15, 2025

LETTER

Form UPLOAD - SEC-generated letter

Aug 4, 2025

EFFECT

Form EFFECT - Notice of Effectiveness

Dec 27, 2023

CORRESP

Form CORRESP - Correspondence

Dec 21, 2023

LETTER

Form UPLOAD - SEC-generated letter

Dec 19, 2023